{"id":"W2795095949","doi":"10.1111/jns.12267","title":"A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol","year":2018,"lang":"en","type":"article","venue":"Journal of the Peripheral Nervous System","topic":"Peripheral Neuropathies and Disorders","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Polyradiculoneuropathy; Tolerability; Chronic inflammatory demyelinating polyneuropathy; Clinical endpoint; Internal medicine; Adverse effect; Randomized controlled trial; Clinical trial; Corticosteroid; Antibody; Pediatrics; Immunology; Guillain-Barre syndrome","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008042164,0.003982663,0.004772234,0.0007545768,0.001064547,0.001961542,0.002443346,0.00353785,0.01371432],"category_scores_gemma":[0.005052162,0.001887638,0.002092927,0.001007208,0.001920395,0.001358051,0.0008813832,0.004597598,0.003871978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001374368,"about_ca_system_score_gemma":0.004891502,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001167419,"about_ca_topic_score_gemma":0.002662677,"domain_scores_codex":[0.9967037,0.002130743,0.0001708498,0.000355419,0.0002681523,0.0003711101],"domain_scores_gemma":[0.9977222,0.0005228517,0.0004576737,0.0002547874,0.0002506498,0.0007918948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9729387,0.01055546,0.0005464114,0.001221461,0.0004824368,0.00008509996,0.00008605563,0.0006395383,0.002240782,0.0004025901,0.002509324,0.00829218],"study_design_scores_gemma":[0.9760513,0.02101567,0.0004859806,0.00004623405,0.0001294583,0.00002059203,0.00001195258,0.0002003539,0.0001392522,0.0001357178,0.001748996,0.00001450528],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.2450026,0.003706345,0.005746714,0.001708796,0.001801273,0.7276073,0.008095804,0.0004253274,0.005905912],"genre_scores_gemma":[0.243462,0.003558752,0.01063207,0.00397391,0.0008303206,0.7246439,0.005386236,0.00008618933,0.007426596],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.01371432,"threshold_uncertainty_score":0.04587895,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01173143458194222,"score_gpt":0.2613315869980229,"score_spread":0.2496001524160807,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}